Search
Now showing items 1-10 of 398
Triple-negative breast cancer: the reality in Chile and in Latin America
(2019)
Breast cancer is the leading cause of cancer death among women worldwide. While triple-negative breast cancer is less common among various sub-types of breast cancer, it tends to affect younger women and is more aggressive, ...
Cancer-related worry and risk perception in Brazilian individuals seeking genetic counseling for hereditary breast cancer
(Sociedade Brasileira de Genética, 2020)
Curcumin and paclitaxel induce cell death in breast cancer cell lines
(Spandidos Publications, 2018)
Breast cancer is one of the major health issues confronting women; however, treatment with conventional chemotherapeutic drugs is limited. Currently, paclitaxel is used as a therapeutic clinical agent to treat breast cancer ...
Curcumin and paclitaxel induce cell death in breast cancer cell lines
(2018)
Breast cancer is one of the major health issues confronting women; however, treatment with conventional chemotherapeutic drugs is limited. Currently, paclitaxel is used as a therapeutic clinical agent to treat breast cancer ...
Prevalence and impact of founder mutations in hereditary breast cancer in Latin America
(Sociedade Brasileira de Genética, 2015)
Association of B7-H4, PD-L1, and tumor infiltrating lymphocytes with outcomes in breast cancer
(2018)
B7-H4 (VTCN1) is a member of the CD28/B7 family of immune co-inhibitory molecules. The relationship of tumor and stromal B7-H4 protein expression with PD-L1, tumor infiltrating lymphocytes (TILs) and its association with ...
Triple-negative breast cancer: the reality in Chile and in Latin America
(Facultad de Medicina y Ciencia, 2019)
Breast cancer is the leading cause of cancer death among women worldwide. While triple-negative breast cancer is less common among various sub-types of breast cancer, it tends to affect younger women and is more aggressive, ...